Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.French biotech company Exonhit, which develops therapeutic and diagnostic products, has reported total revenues of EUR2.44m for the six months (H1) ended 30 June 2011, a decrease of 56% compared to EUR5.47m for the same period in 2010.
Subscribe to our email newsletter
Exonhit has reported net loss of EUR4.6m for the six months ended 30 June 2011, compared to EUR1.09m for the same period in 2010.
For the six months ended 30 June 2011, the company’s loss from operations were EUR4.65m, compared to EUR1.71m for the same period prior year.
ExonHit Management board president Loic Maurel said during this semester Exonhit reached significant milestones, in line with their plan.